Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges

Seminars in Immunology · Published 2025-06-23 · DOI 10.1016/j.smim.2025.101975

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.smim.2025.101975

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• From immunobiology to intervention: Pathophysiology of autoimmune encephalitis · Seminars in Immunology · 2025 · Same journal
• Global aspects of celiac disease and food allergy · Seminars in Immunology · 2025 · Same journal
• Antiviral humoral immunity: Enemy or ally of viral immunotherapy? · Seminars in Immunology · 2025 · Same journal
• Three’s company: The cooperative signals behind the differentiation of Th9 cells · Seminars in Immunology · 2025 · Same journal
• Autoimmune diabetes and targets for immunomodulation · Seminars in Immunology · 2025 · Same journal
• The multifaceted role of B lymphocytes in type 1 diabetes · Seminars in Immunology · 2026 · Same journal
• Reovirus oncolysis and the next frontiers for this unique oncoviral immunotherapy · Seminars in Immunology · 2025 · Same journal
• Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses · Seminars in Immunology · 2026 · Same journal
• Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity · Seminars in Immunology · 2025 · Same journal
• The spatial and single-cell landscape of skin: Charting the multiscale regulation of skin immune function · Seminars in Immunology · 2025 · Same journal